Trial Profile
A RANDOMISED, PLACEBO-CONTROLLED, CROSSOVER STUDY TO EVALUATE THE EFFECT OF LINACLOTIDE ON COLONIC MOTILITY ASSESSED WITH INTRALUMINAL COLONIC MANOMETRY IN HEALTHY SUBJECTS
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Aug 2014
Price :
$35
*
At a glance
- Drugs Linaclotide (Primary)
- Indications Colorectal cancer; Constipation; Irritable bowel syndrome
- Focus Pharmacodynamics
- Acronyms LINACLOTIDEPLACEBO
- 22 Aug 2014 New trial record